Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Mark Prausnitz
University of Colorado Denver, Department: Pharmacology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Clearside Biomedical
Equity Interest - Publicly traded entity (e.g., stock, stock option, or other ownership interest)
NA
Suprachroidal Drug Delivery for Retina Disorders
Age-related macular degeneration is the leading cause of blindness in the elderly. The purpose of this project is to develop a new route of drug administration that will enable more effective, safe, and minimally invasive approaches to treat this disease. The innovative technologies developed in this project will be applied to several therapeutic agents to treat retinal disease in an animal model.
Filed on July 18, 2016.
Tell us what you know about Mark Prausnitz's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Mark Prausnitz filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Mark Prausnitz | Georgia Institute of Technology | Conflict of Interest | Micron Biomedical | Value cannot be readily determined |
| Mark Prausnitz | Georgia Institute of Technology | Conflict of Interest | Clearside Biomedical | Value cannot be readily determined |
| Mark Prausnitz | Georgia Institute of Technology | Conflict of Interest | Micron Biomedical | Value cannot be readily determined |
Other search results for: “Mark Prausnitz”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Mark Prausnitz | Georgia Institute of Technology | Conflict of Interest | Husch Blackwell | |
| Mark Prausnitz | Georgia Institute of Technology | Conflict of Interest | Theranos | |
| Mark Prausnitz | Georgia Institute of Technology | Conflict of Interest | Pearl Cohen Zekek Latzer Baratz LLP | |
| Mark Prausnitz | Georgia Institute of Technology | Conflict of Interest | Moonlight Therapeutics |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.